US FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the … | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.
MENU

US FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the …

US FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the …
Peptide News from Biotech and Pharma, Raw News September 17, 2017

PARIS, France I September 18, 2017 I Ipsen (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that the U.S. Food and Drug Administration (FDA) ...

Email

support@boulderpeptide.org

s2Member®
loading...